Clinical Trial Title
Registry of Deep Brain Stimulation with the VERCISE™ SystemNational Clinical Trial Number:
NCT02071134Contact Information
Neepa Patel
Clinical Trial Protocol Description:
This study will document characteristics of real-world outcomes for Boston Scientific Corporation’s commercially approved Vercise™ System for Deep Brain Stimulation (DBS), when used according to the applicable Instructions for Use.
If you have talked with your neurologist and plan to have deep brain stimulation surgery using the Vercise™ System, you may qualify for this registry study.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Plan to receive currently available Vercise™ System and/or any new Commercially Approved components (i.e., leads, extension, Adaptor, CP, etc.) compatible with the Vercise System.
- Are at least 18 years of age.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
Neepa J. Patel, MD
Contact Information
Neepa Patel
(312) 563-2900 (mention Vercise registry)
Clinical Trial Location
Rush University Medical Center